newsfilter
← Latest News
GlobeNewswire·

Spring Bank Stops Dosing of Inarigivir Patients in Phase 2 Program

HOPKINTON, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...